Skip to Main content Skip to Navigation
Journal articles

LOXL2 is a prognosis biomarker and a potential therapeutic target in intrahepatic cholangiocarcinoma

Abstract : no abstract
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01310762
Contributor : Laurent Jonchère <>
Submitted on : Tuesday, May 3, 2016 - 10:18:48 AM
Last modification on : Wednesday, May 16, 2018 - 11:23:31 AM

Links full text

Identifiers

Citation

D. Bergeat, A. Fautrel, Bruno Turlin, A. Merdrignac, M. Rayar, et al.. LOXL2 is a prognosis biomarker and a potential therapeutic target in intrahepatic cholangiocarcinoma. HPB, Wiley, 2016, Abstracts of the 11th International Congress of the European-African Hepato-Pancreato-Biliary Association, 21-24 April 2015, Manchester, UK, 18, Supplement 2, pp.e863. ⟨10.1016/j.hpb.2016.01.490⟩. ⟨hal-01310762⟩

Share

Metrics

Record views

151